<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Antileshmanial 2-substituted quinolines : in vitro behaviour towards biological components</dc:title>
  <dc:creator>Desrivot, J.</dc:creator>
  <dc:creator>Herrenknecht, C.</dc:creator>
  <dc:creator>Ponchel, G.</dc:creator>
  <dc:creator>Garbi, N.</dc:creator>
  <dc:creator>Prina, E.</dc:creator>
  <dc:creator>/Fournet, Alain</dc:creator>
  <dc:creator>Bories, C.</dc:creator>
  <dc:creator>Figad&#xE8;re, B.</dc:creator>
  <dc:creator>Hocquemiller, B.</dc:creator>
  <dc:creator>Loiseau, P.M.</dc:creator>
  <dc:subject>LEISHMANIOSE</dc:subject>
  <dc:subject>PARASITE</dc:subject>
  <dc:subject>METHODE DE LUTTE</dc:subject>
  <dc:subject>MEDICAMENT</dc:subject>
  <dc:subject>EFFICACITE</dc:subject>
  <dc:subject>EXPERIMENTATION IN VITRO</dc:subject>
  <dc:subject>CHROMATOGRAPHIE EN PHASE LIQUIDE</dc:subject>
  <dc:subject>EXTRACTION</dc:subject>
  <dc:subject>TEMPERATURE</dc:subject>
  <dc:subject>ETUDE EXPERIMENTALE</dc:subject>
  <dc:subject>ETUDE COMPARATIVE</dc:subject>
  <dc:subject>QUINOLINE</dc:subject>
  <dc:subject>PHARMACOCINETIQUE</dc:subject>
  <dc:subject>CYTOTOXICITE</dc:subject>
  <dc:subject>CONCENTRATION</dc:subject>
  <dc:subject>HEMATOCRITE</dc:subject>
  <dc:date>2007</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010040724</dc:identifier>
  <dc:identifier>fdi:010040724</dc:identifier>
  <dc:identifier>Desrivot J., Herrenknecht C., Ponchel G., Garbi N., Prina E., Fournet Alain, Bories C., Figad&#xE8;re B., Hocquemiller B., Loiseau P.M.. Antileshmanial 2-substituted quinolines : in vitro behaviour towards biological components. 2007, 61 (7),  441-450</dc:identifier>
  <dc:language>EN</dc:language>
</oai_dc:dc>
